Cortical Pyramidal Neurons In Corticobasal Degeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Corticobasal degeneration (CBD) is a progressive neurodegenerative disorder characterized by asymmetric cortical and basal ganglia dysfunction. Cortical pyramidal neuron degeneration is a central feature, contributing to the apraxia, cortical sensory loss, and executive deficits.
- Astrocytic plaques: Cortical astrocyte involvement
- Thread-like inclusions: Neuronal processes
- Ballooned neurons: Cytoskeletal abnormalities
- Coiled bodies: Oligodendroglial tau
| Feature |
Description |
| Neuronal loss |
30-60% in affected cortex |
| Atrophy |
Parietal > frontal > temporal |
| Asymmetry |
Contralateral to most affected side |
- Betz cells: Large pyramidal neurons
- Pyramidal tract degeneration: Upper motor neuron signs
- Apraxia: Cortical sensorimotor disconnection
- Posterior parietal: Sensory integration deficits
- Cortical sensory loss: Astereognosis, agraphesthesia
- Neglect: Spatial awareness deficits
- Executive dysfunction: Planning, organization deficits
- Behavioral changes: Disinhibition, apathy
- Working memory: Frontostriatal circuit disruption
- Isoform composition: 4R tau predominant
- Post-translational modifications: Hyperphosphorylation
- Aggregation pathway: Soluble oligomers to fibrils
- Axonal transport defects: Tau-mediated microtubule disruption
- Synaptic loss: Correlates with cognitive decline
- Energy failure: Mitochondrial dysfunction
- Akinesia: Movement initiation failure
- Dystonia: Postural abnormalities
- Myoclonus: Cortical origin
- Alien limb: Involuntary movement awareness
- Sensory extinction: Dual stimulation deficits
- Constructional apraxia: Spatial organization loss
- Oligonucleotide therapy: ASO targeting MAPT
- Small molecule inhibitors: Tau aggregation blockers
- Immunotherapy: Anti-tau antibodies
- Botulinum toxin: Dystonia management
- Clonazepam: Myoclonus control
- Physical therapy: Functional maintenance
The study of Cortical Pyramidal Neurons In Corticobasal Degeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Dickson DW, et al. Neuropathology of CBD. Acta Neuropathol. 2020;139(3):369-389.
- Armstrong MJ, et al. Corticobasal degeneration. Mov Disord. 2021;36(11):2543-2561.
- Boxer AL, et al. Advances in CBD therapeutics. Nat Rev Neurol. 2023;19(2):73-90.